Ameritas Investment Partners’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-271
| Closed | -$4.71K | – | 3132 |
|
2024
Q1 | $4.71K | Hold |
271
| – | – | ﹤0.01% | 2956 |
|
2023
Q4 | $3.48K | Hold |
271
| – | – | ﹤0.01% | 3019 |
|
2023
Q3 | $10K | Hold |
271
| – | – | ﹤0.01% | 2835 |
|
2023
Q2 | $10.9K | Hold |
271
| – | – | ﹤0.01% | 2877 |
|
2023
Q1 | $19.7K | Hold |
271
| – | – | ﹤0.01% | 2474 |
|
2022
Q4 | $28.2K | Hold |
271
| – | – | ﹤0.01% | 2398 |
|
2022
Q3 | $25K | Hold |
271
| – | – | ﹤0.01% | 2401 |
|
2022
Q2 | $52K | Hold |
271
| – | – | ﹤0.01% | 1962 |
|
2022
Q1 | $63K | Hold |
271
| – | – | ﹤0.01% | 1924 |
|
2021
Q4 | $107K | Buy |
271
+24
| +10% | +$9.48K | ﹤0.01% | 1635 |
|
2021
Q3 | $110K | Hold |
247
| – | – | ﹤0.01% | 1629 |
|
2021
Q2 | $96K | Hold |
247
| – | – | ﹤0.01% | 1745 |
|
2021
Q1 | $89K | Hold |
247
| – | – | ﹤0.01% | 1741 |
|
2020
Q4 | $121K | Hold |
247
| – | – | 0.01% | 1457 |
|
2020
Q3 | $80K | Buy |
247
+44
| +22% | +$14.3K | ﹤0.01% | 1567 |
|
2020
Q2 | $74K | Buy |
203
+23
| +13% | +$8.38K | ﹤0.01% | 1596 |
|
2020
Q1 | $38K | Hold |
180
| – | – | ﹤0.01% | 1812 |
|
2019
Q4 | $74K | Buy |
180
+29
| +19% | +$11.9K | ﹤0.01% | 1674 |
|
2019
Q3 | $53K | Hold |
151
| – | – | ﹤0.01% | 1848 |
|
2019
Q2 | $76K | Buy |
151
+18
| +14% | +$9.06K | ﹤0.01% | 1670 |
|
2019
Q1 | $132K | Hold |
133
| – | – | 0.01% | 1292 |
|
2018
Q4 | $116K | Hold |
133
| – | – | 0.01% | 1279 |
|
2018
Q3 | $138K | Hold |
133
| – | – | 0.01% | 1336 |
|
2018
Q2 | $122K | Buy |
133
+22
| +20% | +$20.2K | 0.01% | 1398 |
|
2018
Q1 | $108K | Buy |
111
+39
| +54% | +$37.9K | 0.01% | 1433 |
|
2017
Q4 | $33K | Hold |
72
| – | – | ﹤0.01% | 2160 |
|
2017
Q3 | $28K | Hold |
72
| – | – | ﹤0.01% | 2223 |
|
2017
Q2 | $25K | Hold |
72
| – | – | ﹤0.01% | 2328 |
|
2017
Q1 | $37K | Buy |
+72
| New | +$37K | ﹤0.01% | 2030 |
|